A Study Assessing Risk Factors for Oral Mucositis/Stomatitis and Ocular Surface Events in NSCLC and Breast Cancer

NCT06686602 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 13759

Last updated 2025-03-19

No results posted yet for this study

Summary

This study will identify risk factors for oral mucositis/stomatitis and ocular surface events (OSE) in patients with advanced/metastatic non-small cell lung cancer (NSCLC) and advanced/metastatic human epidermal growth factor receptor 2 (HER2)-negative breast cancer.

Conditions

  • Advanced/Metastatic NSCLC
  • Advanced/Metastatic HER2-negative Breast Cancer

Interventions

OTHER

No drug

This is a non-interventional study and no study drug will be administered.

Sponsors & Collaborators

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-09
Primary Completion
2024-12-16
Completion
2025-03-18

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06686602 on ClinicalTrials.gov